These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 20884376)

  • 1. In vitro activity of nicotinamide/antileishmanial drug combinations.
    Gazanion E; Vergnes B; Seveno M; Garcia D; Oury B; Ait-Oudhia K; Ouaissi A; Sereno D
    Parasitol Int; 2011 Jan; 60(1):19-24. PubMed ID: 20884376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro effect of new formulations of amphotericin B on amastigote and promastigote forms of Leishmania infantum.
    Ordóñez-Gutiérrez L; Espada-Fernández R; Dea-Ayuela MA; Torrado JJ; Bolás-Fernandez F; Alunda JM
    Int J Antimicrob Agents; 2007 Oct; 30(4):325-9. PubMed ID: 17631982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Canine leishmaniasis: evolution of the chemotherapeutic protocols].
    Oliva G; Foglia Manzillo V; Pagano A
    Parassitologia; 2004 Jun; 46(1-2):231-4. PubMed ID: 15305724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species.
    Tavares GSV; Mendonça DVC; Lage DP; Antinarelli LMR; Soyer TG; Senna AJS; Matos GF; Dias DS; Ribeiro PAF; Batista JPT; Poletto JM; Brandão GC; Chávez-Fumagalli MA; Pereira GR; Coimbra ES; Coelho EAF
    Acta Trop; 2019 Mar; 191():29-37. PubMed ID: 30586571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro interaction between paromomycin sulphate and four drugs with leishmanicidal activity against three New World Leishmania species.
    de Morais-Teixeira E; Gallupo MK; Rodrigues LF; Romanha AJ; Rabello A
    J Antimicrob Chemother; 2014 Jan; 69(1):150-4. PubMed ID: 23970484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A protein of the leucine-rich repeats (LRRs) superfamily is implicated in antimony resistance in Leishmania infantum amastigotes.
    Genest PA; Haimeur A; Légaré D; Sereno D; Roy G; Messier N; Papadopoulou B; Ouellette M
    Mol Biochem Parasitol; 2008 Mar; 158(1):95-9. PubMed ID: 18164495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraspecies susceptibility of Leishmania (Viannia) braziliensis to antileishmanial drugs: Antimony resistance in human isolates from atypical lesions.
    Rugani JN; Quaresma PF; Gontijo CF; Soares RP; Monte-Neto RL
    Biomed Pharmacother; 2018 Dec; 108():1170-1180. PubMed ID: 30372818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro interactions between sitamaquine and amphotericin B, sodium stibogluconate, miltefosine, paromomycin and pentamidine against Leishmania donovani.
    Seifert K; Munday J; Syeda T; Croft SL
    J Antimicrob Chemother; 2011 Apr; 66(4):850-4. PubMed ID: 21393188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of trifluralin analogues as antileishmanial agents.
    Esteves MA; Fragiadaki I; Lopes R; Scoulica E; Cruz ME
    Bioorg Med Chem; 2010 Jan; 18(1):274-81. PubMed ID: 19926293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimony resistance and trypanothione in experimentally selected and clinical strains of Leishmania panamensis.
    Goyeneche-Patino DA; Valderrama L; Walker J; Saravia NG
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4503-6. PubMed ID: 18824610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leishmania tarentolae: utility as an in vitro model for screening of antileishmanial agents.
    Taylor VM; Muñoz DL; Cedeño DL; Vélez ID; Jones MA; Robledo SM
    Exp Parasitol; 2010 Dec; 126(4):471-5. PubMed ID: 20685203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-throughput Cos-Seq screen with intracellular Leishmania infantum for the discovery of novel drug-resistance mechanisms.
    Fernandez-Prada C; Sharma M; Plourde M; Bresson E; Roy G; Leprohon P; Ouellette M
    Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):165-173. PubMed ID: 29602064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo pharmacodynamics of three novel antileishmanial lead series.
    Van den Kerkhof M; Mabille D; Chatelain E; Mowbray CE; Braillard S; Hendrickx S; Maes L; Caljon G
    Int J Parasitol Drugs Drug Resist; 2018 Apr; 8(1):81-86. PubMed ID: 29425734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of (-)alpha-bisabolol against Leishmania infantum promastigotes.
    Morales-Yuste M; Morillas-Márquez F; Martín-Sánchez J; Valero-López A; Navarro-Moll MC
    Phytomedicine; 2010 Mar; 17(3-4):279-81. PubMed ID: 19577452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antileishmanial activity of azithromycin against Leishmania (Leishmania) amazonensis, Leishmania (Viannia) braziliensis, and Leishmania (Leishmania) chagasi.
    de Oliveira-Silva F; de Morais-Teixeira E; Rabello A
    Am J Trop Med Hyg; 2008 May; 78(5):745-9. PubMed ID: 18458308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The fitness of antimony-resistant Leishmania parasites: lessons from the field.
    Ait-Oudhia K; Gazanion E; Oury B; Vergnes B; Sereno D
    Trends Parasitol; 2011 Apr; 27(4):141-2. PubMed ID: 21216196
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug susceptibility of Leishmania infantum (syn. Leishmania chagasi) isolates from Brazilian HIV-positive and HIV-negative patients.
    Inocêncio da Luz R; Romero GA; Dorval ME; Cruz I; Cañavate C; Dujardin JC; Van Assche T; Cos P; Maes L
    J Antimicrob Chemother; 2011 Mar; 66(3):677-9. PubMed ID: 21393233
    [No Abstract]   [Full Text] [Related]  

  • 18. Combination therapy with nitazoxanide and amphotericin B, Glucantime®, miltefosine and sitamaquine against Leishmania (Leishmania) infantum intracellular amastigotes.
    Mesquita JT; Tempone AG; Reimão JQ
    Acta Trop; 2014 Feb; 130():112-6. PubMed ID: 24239532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leishmania infantum promastigotes: flow cytometry as a possible tool for assessing the effects of drugs on cellular functions.
    Azas N; Di Giorgio C; Delmas F; Gasquet M; Timon-David P
    Exp Parasitol; 1997 Sep; 87(1):1-7. PubMed ID: 9287952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro sensitivity of Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis Brazilian isolates to meglumine antimoniate and amphotericin B.
    Zauli-Nascimento RC; Miguel DC; Yokoyama-Yasunaka JK; Pereira LI; Pelli de Oliveira MA; Ribeiro-Dias F; Dorta ML; Uliana SR
    Trop Med Int Health; 2010 Jan; 15(1):68-76. PubMed ID: 19874570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.